Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 9, 2013, Pages 6269-6279

  Rajasagi, Naveen K ^a   Reddy, Pradeep B J ^a   Mulik, Sachin ^a   Gjorstrup, Per ^b   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b Resolvyx Pharmaceuticals Inc   (United States)

Author keywords

Herpes stromal keratitis; HSV 1; Immunopathology; NPD1

Indexed keywords

ANTIINFLAMMATORY AGENT; CD11B ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; CXCL1 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MICRORNA; NEUROPROTECTIN D1; RX 20001; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SLIT LAMP;

HERPES STROMAL KERATITIS; HSV-1; IMMUNOPATHOLOGY; NPD1;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CORNEAL NEOVASCULARIZATION; CYTOKINES; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KERATITIS, HERPETIC; MICE; MICE, INBRED C57BL; NEUTROPHILS;

EID: 84884251982     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12152     Document Type: Article

References (37)

1. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20:1-13.
2. Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med. 2004;6:1-14.
3. Colin J. Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes. Clin Ophthalmol. 2007;1:441-453.
4. Knickelbein JE, Hendricks RL, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidencebased review. Surv Ophthalmol. 2009;54:226-234.
5. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 2002;25:33-55.
6. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-361.
7. Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev. 2011;111:5922-5943.
8. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution pathways. Nature. 2007;447:869-875.
9. Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol. 2007;178:496-502.
10. Gonzalez-Periz A, Planaguma A, Gronert K, et al. Docosahexanenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J. 2006;20:2537-2539.
11. Duffield JS, Hong S, Vaidya V, et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol. 2006;177:5902-5911.
12. Serhan CN, Gotlinger K, Hong S, et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol. 2006;176:1848-1859.
13. Serhan CN, Fredman G, Yang R, et al. Novel proresolving aspirin-triggered DHA pathway. Chem Biol. 2011;18:976-987.
14. Ariel A, Li PL, Wang W, et al. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem. 2005;280:43079-43086.
15. Bannenberg GL, Chiang N, Ariel A, et al. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol. 2005;174:4345-4355.
16. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A. 2004;101:8491-8496.
17. Gronert K, Maheshwari N, Khan N, Hassan IR, Dunn M, Laniado Schwartzman MA. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem. 2005;280:15267-15278.
18. Biswas PS, Rouse BT. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect. 2005;7:799-810.
19. Kim B, Sarangi PP, Lee Y, Deshpande S, Lee S, Rouse BT. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J Leukocyte Biol. 2006;80:1405-1415.
20. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol. 1992;149:3035-3039.
21. Rajasagi NK, Reddy PB, Suryawanshi A, Mulik S, Gjorstrup P, Rouse BT. Controlling herpes simplex virus induced ocular inflammatory lesions with the lipid derived mediator Resolvin E1. J Immunol. 2011;186:1735-1746.
22. Mulik S, Xu J, Reddy PB, et al. Role of microRNA-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol. 2012;181:525-534.
23. Rajasagi NK, Suryawanshi A, Sehrawat S, et al. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J Immunol. 2012;188:4631-4643.
24. Gimenez F, Suryawanshi A, Rouse BT. Pathogenesis of herpes stromal keratitis-a focus on corneal neovascularization. Prog Retin Eye Res. 2012;33:1-9.
25. Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res. 2006;82:46-54.
26. Lee S, Zheng M, Kim B, Rouse BT. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest. 2002;110:1105-1111.
27. Sarangi PP, Sehrawat S, Suvas S, Rouse BT. IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J Immunol. 2008;180:6297-6306.
28. Tumpey TM, Elner VM, Chen SH, Oakes JE, Lausch RN. Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol. 1994;153:2258-2265.
29. Rowe AM, St Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL. Herpes keratitis. Prog Retin Eye Res. 2013;32:88-101.
30. Thomas J, Gangappa S, Kanangat S, Rouse BT. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol. 1997;158:1383-139.
31. Bromley SK, Mempel TR, Luster AD. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol. 2008;9:970-980.
32. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci. 2008;13:2400-2407.
33. Steinman L. A brief history of Th17, the first major revision in the Th1/Th2 hypothesis of T-cell mediated tissue damage. Nat Med. 2007;13:139-145.
34. Bystrom J, Evans I, Newson J, et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood. 2008;112:4117-4127.
35. Sheets KG, Zhou Y, Ertel MK, et al. Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse. Mol Vis. 2010;16:320-329.
36. Connor KM, Paul J, Giovanni S, et al. Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 13: 2007;868-873.
37. Navarro-Xavier RA, Newson J, Silveira VLF, Farrow SN, Gilroy DW, Bystrom J. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J Immunol. 2010;184:1516-1525.